Demand for weight loss drugs targeting GLP-1 has exploded in recent years, leading to disruptions in supply chains. Here are ...
MedPage Today on MSN2d
ObesityWeek Roundup: Patients More Likely to Ration Weight-Loss DrugsSAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...
Medpage Today on MSN6d
Zepbound's Weight Loss, Cardiometabolic Benefits Hold Up at 3 YearsSAN ANTONIO -- Patients with overweight or obesity lost an average one-fifth of their body weight with the highest dose of ...
All are welcome to join the Options Medical Weight Loss team and the Cary Chamber of ... we're proud that within six months, the average patient loses 30 pounds of fat, including 21 percent ...
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Novo Nordisk said the side effects in trials so far for its experimental obesity drug CagriSema were similar to its GLP-1 ...
Popular weight-loss drugs are helping some runners lose weight and crush PRs. Experts have some real concerns.
A new Northbrook pharma will work to bring its obesity treatment to market that it says holds advantages over Ozempic and its ...
Perrigo intends to put focus at select retailers on over-the-counter medications that relieve the side effects of GLP-1 drugs ...
All are welcome to join the Options Medical Weight Loss team and the Cary Chamber of Commerce for grand re-opening festivities, October 23 ST. PETERSBURG, Fla., Oct. 21, 2024 /PRNewswire ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback